Straton Emma, Bryant Breana L, Kang Leyi, Wang Christine, Barber John, Perkins Amanda, Gallant Letitia, Marks Brynn, Agarwal Shivani, Majidi Shideh, Monaghan Maureen, Streisand Randi
Children's National Hospital, Washington DC, United States of America.
Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Contemp Clin Trials. 2024 May;140:107493. doi: 10.1016/j.cct.2024.107493. Epub 2024 Mar 7.
Type 1 diabetes management is often challenging during adolescence, and many youth with type 1 diabetes struggle with sustained and optimal continuous glucose monitor (CGM) use. Due to racial oppression and racially discriminatory policies leading to inequitable access to quality healthcare and life necessities, racially minoritized youth are significantly less likely to use CGM.
ROUTE-T1D: Research on Optimizing the Use of Technology with Education is a pilot behavioral intervention designed to promote optimal CGM use among racially minoritized youth with type 1 diabetes. Intervention strategies include problem solving CGM challenges and promoting positive caregiver-youth communication related to CGM data.
This randomized waitlist intervention provides participants with access to three telemedicine sessions with a Certified Diabetes Care and Education Specialist. Caregiver participants are also connected with a peer-parent coach.
Hypothesized findings and anticipated challenges are discussed. Future directions regarding sustaining and optimizing the use of diabetes technology among racially minoritized pediatric populations are reviewed.
1型糖尿病的管理在青少年时期往往具有挑战性，许多患有1型糖尿病的青少年在持续且最佳地使用持续葡萄糖监测（CGM）方面存在困难。由于种族压迫和种族歧视政策导致获得优质医疗保健和生活必需品的机会不平等，少数族裔青少年使用CGM的可能性显著降低。
ROUTE-T1D：通过教育优化技术使用的研究是一项试点行为干预措施，旨在促进患有1型糖尿病的少数族裔青少年最佳地使用CGM。干预策略包括解决CGM面临的挑战以及促进照顾者与青少年之间就CGM数据进行积极沟通。
这项随机等待名单干预措施为参与者提供了与糖尿病护理和教育认证专家进行三次远程医疗会诊的机会。照顾者参与者还与一位同伴家长教练建立联系。
讨论了假设的研究结果和预期挑战。回顾了在少数族裔儿科人群中维持和优化糖尿病技术使用的未来方向。
